PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pfizer Worldwide Research, Development & Medical, Groton, CT, 06340, USA. Electronic address: natasha.catlin@pfizer.com.\', \'Pfizer Worldwide Research, Development & Medical, Groton, CT, 06340, USA.\', \'Pfizer Worldwide Research, Development & Medical, Pearl River, NY, 10965, USA.\', \'Pfizer Worldwide Research, Development & Medical, Cambridge, MA, 02139, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0890-6238(22)00012-010.1016/j.reprotox.2022.01.006
?:hasPublicationType
?:journal
  • Reproductive toxicology (Elmsford, N.Y.)
is ?:pmid of
?:pmid
?:pmid
  • 35101563
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Reproductive and developmental safety of nirmatrelvir (PF-07321332), an oral SARS-CoV-2 Mpro inhibitor in animal models.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35101563>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35101563>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all